Polpharma Pharmaceutical Works - API Manufacturer

drukuj

World class service   

Polpharma provides a one-stop shopping solution of integrated services ranging from API development

to finished dosage formulation and scale-up capabilities based on in-house or customer developed technology and the support of the registration file.

 

Full support from molecule development to drug delivery


We offer:

  • Development, production and marketing of generic APIs
  • Custom synthesis and toll manufacturing
  • Intellectual Property review services
  • Non-infringing process development
  • US and European DMFs in a common format
  • Wide reaction classes in FDA approved facilities
  • Multipurpose production lines
  • High GMP standards
  • Product quality

 

Cost-effective solutions tailored to the customers` needs

We constantly seek ways to add value to everything that we do for our customers. We ensure to keep our API portfolio updated and expand it with new, attractive compounds.

Our cGMP capacity combined with a short development time and competitive pricing make us a natural choice for pharmaceutical companies interested in outsourcing their manufacturing activities. We have gained an exceptional reputation among our customers worldwide for the quality of our contract manufacturing services.

 

Out-licensing offer

Our services include EU standard dossiers for finished dosage formulations based on APIs developed in-house or sourced externally. Our out-licensing portfolio secures the most comprehensive offer for our clients.

 

Quality, optimization and customer satisfaction are the driving forces behind our work

Our products are manufactured in accordance with the most stringent requirements of our customers and health authorities. DMF documentation for all our products is prepared in accordance with the latest requirements of EDQM (CEP), ICH (EuDMF, CTD), and FDA (US DMF).

Material and product testing is performed according to the European and United States Pharmacopeias. However, our products can be additionally tested in compliance with the customer’s specifications.

Latest news

CEP for Baclofen available

Monday, 02-01-2012
Polpharma has been granted Certificate of Suitability (CEP) by the European Directorate for the Quality of...

Polpharma – the most innovative company in Poland

Friday, 20-05-2011
Polpharma ranked first as the most innovative company in Poland, in a research study run by the Institute...

Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex

Friday, 08-10-2010
Polpharma has inaugurated a new state of the art 300 sq.m. Process Development Labs complex for the...

Co-operation between Polpharma and RPG Life Sciences

Tuesday, 05-10-2010
RPGLS and Polpharma announced their co-operation in the development and manufacture of Active...
© POLPHARMA S.A. All rights reserved.
Realizacja: Ideo